CIK 0001410098
- Non-accelerated filer
CorMedix Inc.
Sign in to watch- Ticker
- CRMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 908-517-9500
- Business address
- 389 INTERPACE PKWY, SUITE 450, PARSIPPANY, NJ, 07054
- Open-market buys, last 90 days
- $588,195
- in 4 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$588,195. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-01-10 | Dillione Janet Director | Grant or award · Stock Option (Right to Buy Common Stock) | +75,000 | 75,000 | ||
| 2018-12-31 | ARMSTRONG JR. JOHN L. Exec VP of Tech Operations | Exercise or conversion | +18,029 | 306,890 | ||
| 2018-12-31 | ARMSTRONG JR. JOHN L. Exec VP of Tech Operations | Exercise or conversion · Restricted Stock Units | −18,029 | 0 | ||
| 2018-12-20 | Lefkowitz Steven W Director | Purchase | +20,000 | $1.18 | $24K | 135,757 |
| 2018-12-20 | Khan Mehmood Director | Purchase | +100,000 | $1.24 | $124K | 564,583 |
| 2018-12-14 | Kaplan Myron Director | Purchase | +50,000 | $1.47 | $73K | 431,166 |
| 2018-12-05 | Masson Elizabeth EVP, Head of Clinical Ops. | Exercise or conversion | +40,000 | $0.29 | $12K | 40,000 |
| 2018-12-05 | Masson Elizabeth EVP, Head of Clinical Ops. | Exercise or conversion · Stock Option (Right to Buy Common Stock) | −40,000 | 270,000 | ||
| 2018-11-29 | ARMSTRONG JR. JOHN L. Exec VP of Tech Operations | Purchase | +250,000 | $1.45 | $363K | 288,861 |
| 2018-11-27 | Baluch Khoso Chief Executive Officer | Purchase | +21,500 | $1.21 | $26K | 250,373 |
| 2018-11-27 | Cook Robert W. Chief Financial Officer | Purchase | +25,000 | $1.17 | $29K | 127,083 |
| 2018-11-26 | Baluch Khoso Chief Executive Officer | Purchase | +3,500 | $1.28 | $4K | 228,873 |
| 2018-11-23 | Kaplan Myron Director | Purchase | +50,000 | $1.30 | $65K | 371,166 |
| 2018-11-14 | Dillione Janet Director | Grant or award · Phantom Stock | +6,637 | $1.13 | $7K | 6,637 |
| 2018-11-14 | Dillione Janet Director | Grant or award · Phantom Stock | +6,637 | $1.13 | $7K | 6,637 |
| 2018-11-06 | Kaplan Myron Director | Exercise or conversion | +5,000 | 321,166 | ||
| 2018-11-06 | Kaplan Myron Director | Exercise or conversion · Restricted Stock Units | −5,000 | 0 | ||
| 2018-10-12 | Gelbfish Gary A. Director | Exercise or conversion | +1,000,000 | $1.05 | $1.1M | 3,111,121 |
| 2018-10-12 | Gelbfish Gary A. Director | Shares withheld for taxes | −468,750 | $2.24 | $1.1M | 2,642,371 |
| 2018-10-12 | Gelbfish Gary A. Director | Exercise or conversion · Series B Common Stock Warrant | −1,000,000 | 0 |
Page 17 of 24 · 463 trades